Friday 6 November 2026 Export MRK’s income statement to Excel — free account

Merck & Co., Inc.

MRK Healthcare Drug Manufacturers General

Merck & Co., Inc.’s revenue for fiscal 2025 (year ended December 2025) was $65.0 billion, up 1.31% from fiscal 2024.

Revenue: +4.68%
EPS: −130.7%
Free cash flow: +77.0%
Total debt: +50.4%

Quarter to September 2026, against a year earlier

146.65 0.29 −0.20%

Follow MRK

Alert me

Market cap: $362.5B
P/E: 118×
Fwd P/E: 109×
Dividend yield: 2.31%
F-score: 4/9
Altman Z: 3.77
Beneish M: −2.27
Dividend safety: 74/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Merck & Co., Inc. (MRK) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Merck & Co., Inc. (MRK) trades at a P/B ratio of 8.6×. Over the past ten years it has ranged from 2.8× (September 2015) to 9.2× (August 2026); the current reading is higher than 99% of that period. That is above the Drug Manufacturers General industry median of 5.2× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/MRK/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Merck &amp; Co., Inc. P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/MRK/metrics/pb-ratio">Merck &amp; Co., Inc. (MRK) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	5.0×	(7.93%)
FY2024	5.4×	(28.84%)
FY2023	7.6×	24.94%
FY2022	6.1×	20.55%
FY2021	5.1×	(35.53%)
FY2020	7.9×	(9.20%)
FY2019	8.7×	18.49%
FY2018	7.3×	70.54%
FY2017	4.3×	7.57%
FY2016	4.0×	25.65%

Period	P/B ratio	Change
Sep 2026	8.5×	13.08%
Jun 2026	7.6×	16.77%
Mar 2026	6.5×	29.45%
Dec 2025	5.0×	23.97%
43 more quarters	Free account

Against its own ten years

Low 2.8× High 9.2×

Ten-year median 5.6×

Current reading's percentile 98

Company	P/B ratio
ABBV AbbVie Inc. compare	n/m
PFE Pfizer Inc. compare	1.9×
NVO Novo Nordisk A/S compare	5.2×
AZN AstraZeneca PLC compare	5.6×
JNJ Johnson & Johnson compare	8.1×
NVS Novartis AG compare	8.2×
MRK Merck & Co., Inc.	8.6×
GILD Gilead Sciences, Inc. compare	16.1×
AMGN Amgen Inc. compare	21.4×
Drug Manufacturers General industry median	5.2×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

Merck & Co., Inc. (MRK) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on MRK

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on MRK

Stockrow Weekly